Krideep Pharmaceuticals Private Limited
About Krideep Pharmaceuticals Private Limited
Data last updated:
Krideep Pharmaceuticals Private Limited is a private limited company based in Nanded, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 02 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2013PTC247742. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Krishnakumar Dattatraya Padamwar and Prasanna Krishna Kumar Padamwar.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Sathe Nagar Ward No. 13 Kandhar, Nanded, Maharashtra, India – 431714.
As per the financials filed for FY 2018, the company reported a revenue of ₹21.65 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹6.66 Lakh (net margin -30.8%) and EBITDA of -₹6.47 Lakh (EBITDA margin -29.9%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Krideep Pharmaceuticals Private Limited's registered office is in Nanded, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSathe Nagar Ward No. 13 Kandhar, Nanded, Maharashtra, India – 431714
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Krideep Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Krideep Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Krideep Pharmaceuticals Private Limited, buy the company report.
Financials of Krideep Pharmaceuticals Private Limited
FY 2018 filings availableKrideep Pharmaceuticals Private Limited reported revenue of ₹21.65 Lakh (down 8% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 68%. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹6.47 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹6.66 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -29.9% | |||
| Net Profit Margin | -30.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Krideep Pharmaceuticals Private Limited, buy the company report.
Board of directors of Krideep Pharmaceuticals Private Limited
Krideep Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnakumar Dattatraya Padamwar | Director | 02 Sep 2013 | 13 Years 2 Months | Current |
| Prasanna Krishna Kumar Padamwar | Additional Director | 07 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Krideep Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vnox Pharmaceuticals Private Limited | ₹21.76 Lakh (FY 2025) | 119.0% | Panchkula, Haryana, India | |||
| Gurudev Pharmaceuticals (OPC) Private Limited | ₹21.71 Lakh (FY 2025) | 22.0% | Kalyan, Maharashtra, India | |||
| Krideep Pharmaceuticals Private Limitedthis company | ₹21.65 Lakh (FY 2018) | -₹6.66 Lakh | -30.8% | -8.0% | Nanded, Maharashtra, India | |
| Mundus Pharmaceuticals Private Limited | ₹21.58 Lakh (FY 2024) | -11.0% | Lucknow, Uttar Pradesh, India | |||
| Medigrowth Pharmaceuticals Private Limited | ₹21.48 Lakh (FY 2023) | 64.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Krideep Pharmaceuticals Private Limited, buy the company report.
Auditor
Krideep Pharmaceuticals Private Limited is audited by H S SOHONY AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H S SOHONY AND COMPANY | FY 2017 | 110330W |
Shareholding
The shareholding of Krideep Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Krideep Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Krideep Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Krideep Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Krideep Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Krideep Pharmaceuticals Private Limited, buy the company report.
Recent activity
Krideep Pharmaceuticals Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Deepali Krishnakumar Padamwar ceased to be Director on 07 Sep 2018.
Frequently asked questions
Krideep Pharmaceuticals is an active private limited company based in Nanded, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 02 September 2013 (13+ years old) and is registered under CIN U24230MH2013PTC247742.
Krideep Pharmaceuticals has 2 current directors:
- Krishnakumar Dattatraya Padamwar - Director
- Prasanna Krishna Kumar Padamwar - Additional Director
The latest financial statements of Krideep Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
No. Krideep Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Krideep Pharmaceuticals is U24230MH2013PTC247742. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Krideep Pharmaceuticals was incorporated on 02 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Krideep Pharmaceuticals by revenue are Vnox Pharmaceuticals Private Limited, Gurudev Pharmaceuticals (OPC) Private Limited, Mundus Pharmaceuticals Private Limited, Medigrowth Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Deepali Krishnakumar Padamwar ceased to be Director on 07 Sep 2018. Prasanna Krishna Kumar Padamwar was appointed as Additional Director on 07 Sep 2018. Krishnakumar Dattatraya Padamwar was appointed as Director on 02 Sep 2013.
The registered office of Krideep Pharmaceuticals is at Sathe Nagar Ward No. 13 Kandhar, Nanded, Maharashtra, India – 431714.
Krideep Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Krideep Pharmaceuticals is active non-compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
